Vancomycin and linear IgA bullous dermatosis

Abstract

Vancomycin is a broad-spectrum antibiotic that is considered an optimal parenteral treatment for many infections, including septicemia, pneumonia, cellulitis, endocarditis, and meningitis caused by methicillin-resistant Staphylococcus aureus. It is the first-line treatment for the increasing health care-associated infection Clostridium difficile pseudomembranous colitis. More side effects are being reported secondary to increased vancomycin use. Of those side effects, skin reactions are becoming more recognized by physicians.

Keywords

• Vancomycin, methicillin-resistant Staphylococcus aureus, linear IgA bullous dermatosis, vancomycin skin reactions